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Abstract
Introduction/Objectives:  Surgical  site  infection  (SSI)  in  vascular  surgery  is  a  complication  that
may lead  not  only  to  healing  problems,  but  also  limb  loss  and  risk  of  death.  The  incidence  of
surgical site  infection  at  the  groin  after  vascular  procedures  ranges  among  3%  to  44%.  The  aim
of this  study  is  to  review  the  incidence  of  groin  infection  in  our  department  and  the  degree  of
correlation  between  infection,  known  risk  factors  and  preventing  measures.
Methods:  Retrospective  review  of  consecutive  arterial  vascular  surgeries  in  a  university  central
hospital during  one  year.  Patients  undergoing  groin  incisions  were  studied  according  to  baseline
demographics,  clinical  characteristics,  active  infection,  previous  inguinal  access,  antithrom-
botic therapy,  indication  for  intervention,  prophylactic  antibiotic  use,  type  of  intervention  and
type of  graft  used.  Wound  site  infections  over  a  30-day  period  were  registered  and  graded
based on  Szilagyi  classiﬁcation.  On  patients  with  documented  groin  infection,  the  presentation
timing,  modality  of  treatment  (surgical  and  non-surgical)  and  time  of  healing  were  recorded.
Data were  analyzed  by  using  SPSS  18.0  version  software.
Results:  From  January  to  December  2013,  1266  vascular  surgeries  were  performed.  Of  these,
782 were  arterial  vascular  procedures,  279  by  inguinal  approach,  with  a  total  of  358  groin  inci-
sions. Our  base  population  included  241  patients  (31  patients  with  more  than  one  procedure
in a  year).  Total  infection  rate  was  4.7%  (17/358  groin  incisions).  All  Szilagyi  I  (n  =  4)  resolved
with antibiotic  only;  three  of  the  ten  Szilagyi  II  infections  needed  drainage/debridement  at
operation  room;  the  other  Szilagyi  II  resolved  with  antibiotic  and  wound  care.  All  Szilagyi  III
infections  (n  =  3)  were  treated  with  bypass  removal,  and  in  two  patients  an  in  situ  revascu-
larization  was  performed.  These  two  patients  died  from  sepsis.  Identiﬁcation  of  the  infectingtients,  with  the  most  common  isolated  agent  being  Pseudomonas.agent was  possible  in  9  pa
Hypertension  was  signiﬁcantly  associated  with  a  higher  risk  of  SSI  (p  =  0.033).
Discussion/Conclusions:  In  our  department,  the  infection  rate  of  the  inguinal  approach  equals
the best  international  standards  described.  These  results  may  be  the  outcome  of  a  carefully
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planned  strategy  of  infection  control.  Arising  from  the  fact  that  groin  SSI  is  a  low  incidence
event, correlations  between  suspected  risk  factors  and  this  infection  are  hard  to  establish.
Longer follow-ups  would  be  useful  for  identiﬁcation  of  all  groin  infections.
© 2014  Sociedade  Portuguesa  de  Angiologia  e  Cirurgia  Vascular.  Published  by  Elsevier  España,
S.L.U. All  rights  reserved.
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Infec¸ão da  ferida  cirúrgica  inguinal  na  cirurgia  vascular.  Incidência  de  um  ano  de  uma
instituic¸ão
Resumo
Introduc¸ão/Objetivos:  A  infec¸ão  do  local  cirúrgico  na  cirurgia  vascular  é  uma  complicac¸ão  que
não só  implica  atrasos  na  cicatrizac¸ão,  mas  que  pode  levar  a  perda  de  membro  e  a  risco  de  vida
para o  paciente.  A  incidência  descrita  de  infec¸ão  da  ferida  cirúrgica  inguinal  após  procedimentos
vasculares  varia  de  3  a  44%.  Este  estudo  tem  como  objetivo  quantiﬁcar  a  incidência  de  infec¸ão
inguinal no  nosso  servic¸o  e  estabelecer  níveis  de  correlac¸ão  com  fatores  de  risco  e  medidas
preventivas.
Métodos:  Estudo  retrospetivo  das  cirurgias  vasculares  arteriais  realizadas  num  hospital  uni-
versitário  durante  um  ano.  Pacientes  com  abordagem  inguinal  foram  estudados  segundo
características  clínicas  e  demográﬁcas,  infec¸ão  ativa,  acesso  inguinal  prévio,  terapia  antitrom-
bótica, indicac¸ão  cirúrgica,  antibioterapia  proﬁlática,  tipo  de  intervenc¸ão  e  tipo  de  enxerto.
Foram registadas  as  infec¸ões  do  local  cirúrgico  e  classiﬁcadas  segundo  Szilagyi.  Nos  pacientes
com infec¸ão,  documentamos  o  tempo  de  apresentac¸ão,  tratamento  e  tempo  de  cicatrizac¸ão.
Os dados  foram  analisados  no  SPSS  18.0.
Resultados:  De  janeiro  a  dezembro  de  2013,  foram  realizadas  1266  cirurgias  vasculares,
das quais  782  arteriais.  Destas,  279  tiveram  abordagem  inguinal,  com  um  total  de  358
incisões inguinais  e  uma  amostra  populacional  de  241  pacientes  (31  reintervencionados).
A taxa  de  infec¸ão  foi  de  4,7%  (17/348  incisões).  Todas  as  infec¸ões  Szilagyi  I (n  =  4)
resolveram  com  uso  exclusivo  de  antibiótico.  Três  das  dez  infec¸ões  Szilagyi  II  necessitaram
de drenagem/desbridamento  no  bloco;  as  restantes  Szilagy  II  resolveram  com  antibiótico  e
cuidados de  penso.  Nas  infec¸ões  Szilagyi  III  (n  =  3)  foi  retirada  a  pontagem,  e  em  dois  doentes
foi tentada  a  revascularizac¸ão  in  situ. Esses  dois  pacientes  morreram.  A  identiﬁcac¸ão  do  agente
infecioso foi  possível  em  9  pacientes,  sendo  a  Pseudomonas  o  agente  mais  comum.  A  hipertensão
esteve signiﬁcativamente  associada  a  maior  risco  de  infec¸ão  (p  =  0,033).
Discussão/Conclusões:  A  baixa  taxa  de  infec¸ão  descrita  é  comparável  aos  melhores  resultados
publicados  sobre  este  tema.  Estratégias  de  controlo  de  infec¸ão  reﬁnadas  ao  longo  de  anos  podem
contribuir para  estes  resultados.  Contudo,  sendo  um  evento  de  baixa  incidência,  correlac¸ões
entre  infec¸ão  da  ferida  inguinal  e  fatores  de  risco  são  difíceis  de  estabelecer.  Períodos  de
seguimento  mais  longos  são  necessários  para  a  identiﬁcac¸ão  de  todas  infec¸ões  a  este  nível.
© 2014  Sociedade  Portuguesa  de  Angiologia  e  Cirurgia  Vascular.  Publicado  por  Elsevier  España,
S.L.U. Todos  os  direitos  reservados.
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urgical  site  infection  (SSI)  in  vascular  surgery  is  a  compli-
ation  that  may  lead  not  only  to  healing  problems,  but  also
imb  loss  and  risk  of  death.  It  always  implies  increased  hos-
ital  stay,  hospital  costs  and  morbidity  for  the  patient.1
Groin  incisions  play  a  central  role  in  various  vascular
urgical  procedures.  In  addition  to  their  traditional  use  in
ypass  procedures,  endarterectomies  and  thromboembolec-
omies,  more  than  95%  of  all  percutaneous  interventions  are
erformed  by  femoral  access.2
The  incidence  of  surgical  site  infection  at  the  groin
fter  vascular  procedures  ranges  from  3%  to  44%.3 Factors
t
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fontributing  to  the  increased  incidence  of  SSI  in  this  subset
f  patients  include  disruption  of  lymphatics,  proximity  to
he  perineum  and  prosthetic  graft  placement.  The  increas-
ng  prevalence  infection  by  multiresistant  bacteria  has  been
ssociated  with  worsened  outcomes.4
Although  the  management  of  groin  SSI  is  well  docu-
ented,  there  is  little  published  about  the  incidence  and
lassiﬁcation  of  these  infections.  Szilagyi  et  al  said  that
iabetes,  as  well  as  obesity,  had  a  relatively  small  role  in  ini-
5iating  groin  wound  infection. A  recent  study  showed  that
edo  bypass,  female  gender,  diabetes  and  active  infection
ere  associated  with  a  risk  of  graft  infection  involving  the
emoral  artery.6
5Table  1  Patient  Demographic  and  Clinical  Characteristics.
N  (%)
Men  192/241  79.7%
Age, mean  ±  SD,  years 69  ±  13
BMI, mean  ±  SD,  Kg/m2 25.0  ±  5.1
DM  96/241  39.8%
Hypertension  169/241  70.1%
CVD 39/241  16.2%
CAD 54/241  22.4%
Current  smoking  84/241  34.9%
Previous  smoking  (>  6  months)  73/241  30.3%
Hemodyalisis  14/241  5.8%
Kidney transplantation 9/241 3.7%
* SD, Standard Deviation; BMI, Body Mass Index; DM, Diabetes
Mellitus; CVD, Cerebrovascular Disease; CAD, Coronary Artery
Disease.
59.1%
22.2%
13.3%
2.9% 2.5%
PAOD Acute
ischemia
Aneurysmatic
disease
False
aneurysm
Others
* PAOD, Peripheral Arterial Occlusive Disease
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Besides  the  general  aseptic  measures,  the  only  strategy
that  signiﬁcantly  reduces  the  incidence  of  SSI  is  prophylactic
systemic  antibiotics  administered  only  preoperatively.4
There  is  no  ‘‘gold  standard’’  for  treatment  of  these
infections.  The  initial  treatment  generally  includes  surgical
debridement  and  antibiotics.  Secondary  interventions  have
been  attempted  with  limited  success,  including  rotational
ﬂaps,  wound  vacuum-assisted  closure,  alginate  dressing,
graft  excision  and  extra-anatomic  or  in  situ  bypass  or
patch  replacement  using  autologous,  rifampin-soaked  or
silver-impregnated  materials.7--10The  aim  of  this  study  is  to
describe  the  incidence  of  groin  infection  in  our  vascular
department  and  the  degree  of  correlation  between  infec-
tion/known  risk  factors  and  infection/preventing  measures.
Methods
Retrospective  review  of  consecutive  arterial  vascular  sur-
geries  in  a  central  operating  room  during  one  year.  Patients
undergoing  groin  incisions  for  arterial  vascular  procedures
were  studied  according  to  baseline  demographics,  clinical
characteristics,  active  infection  (ipsilateral  lower  extrem-
ity  infection  occurring  before  vascular  surgery),  previous
inguinal  access  (including  arterial  puncture),  antithrombotic
therapeutic  in  use,  initial  indication  for  intervention,  type
of  intervention  and  type  of  graft  used.
We  reported  the  universal  good  care  practice  that  every
patient  was  subjected  to  before  going  to  the  operating  room.
We  deﬁned  patients  under  prophylactic  antibiotic  those
who  received  intraoperative  antibiotic  or  patients  who  were
under  antibiotic  therapy  at  the  time  of  surgery.
All  patients  underwent  longitudinal  incision  for  femoral
cutdown.
Past  medical  history  of  diabetes  mellitus,  hypertension,
cerebrovascular  disease,  coronary  artery  disease,  smoking  --
including  both  current  and  former  smokers  (>6  months),  end-
stage  renal  disease  on  hemodyalisis  and  history  of  kidney
transplant,  were  recorded.
The  diagnostic  criteria  for  SSI  included  signs/symptoms
of  infection  (pain,  tenderness,  erythema  and/or  swelling),
purulent  drainage  from  the  wound  and  organisms  isolated
from  aseptically  smears  cultures  of  ﬂuid  or  tissue.
Wound  site  infections  over  a  30-day  period  were  regis-
tered  and  graded  based  on  Szilagyi  classiﬁcation.5 Grade
I  infections  had  only  dermal  involvement.  Grade  II  infec-
tions  extended  to  the  subcutaneous  region  and  included
dehiscence  of  wound.  Infections  involving  arterial  graft  were
grade  III.  Patients  with  hematomas  and  noninfected  lympho-
celes  were  also  accounted.
On  patients  with  documented  groin  infection  it  was
registered  the  presentation  timing,  modality  of  treatment
(surgical  and  non-surgical)  and  time  of  healing.
Data  were  entered  in  Microsoft  Excel  2010  and  analyzed
by  using  SPSS  18.0  version  software.
ResultsFrom  January  to  December  2013,  1266  vascular  surger-
ies  were  performed  at  our  central  operating  rooms.  Of
these,  782  were  arterial  vascular  procedures,  279  by  inguinal
approach,  with  a  total  of  358  groin  incisions.  Our  base
w
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pFigure  1  Indications  for  the  intervention.
opulation  had  241  patients  (31  patients  with  more  than  one
rocedure  in  a year).  Demographics  and  clinical  character-
stics  of  our  population  are  presented  in  Table  1.
In  Figure  1, we  illustrated  the  indications  for  the  279
nterventions,  and  in  Table  2  we  listed  the  procedures  per-
ormed.  A  graft  prosthesis  was  used  in  114  of  the  173  bypass
urgeries  (65.9%).  Once  the  patient  was  considered  infected,
o  more  procedures  were  included  in  our  series.  The  peri-
perative  characteristics  are  described  in  Table  3.
All  patients  received  the  universal  good  care  practice
efore  surgery:  previous  bath  with  clorohexidine,  tri-
hotomy  immediately  before  surgery,  skin  antisepsis  with
lcoholic  solution,  intraoperative  glove  change,  closed  suc-
ion  drain  placement,  careful  haemostasis  and  layered
losure.  Prophylactic  antibiotic  was  administered  to  90.3%
f  the  patients.
Total  infection  rate  was  4.7%  (17/358  groins  incisions),
epresenting  complication  in  16  out  of  the  279  procedures
5.7%).  One  patient  had  bilateral  groin  involvement.  There
ere  4  patients  (4  groins)  who  had  Szilagyi  I  infection,  9
atients  (10  groins)  with  Szilagyi  II  and  3  patients  (3  groins)
ith  Szilagyi  III  infection.
The  demographics,  clinical  and  preoperative  characteris-
ics  of  both  infection  and  control  group  were  compared  and
isted  in  Table  4.  Hypertension  was  signiﬁcantly  associated
ith  a  higher  risk  of  SSI  (p  =  0.033).
The  time  to  presentation  with  infection  ranged  from  2
o  25  days  (mean,  13  ±  8).  Incidence  of  infection  by  type  of
rocedure  was  described  in  Table  5.
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Table  2  Procedures.
N  (%)
Bypass  173  62.4%
Axillo-Femoral  5  2.9%
Aorto-Femoral  29  16.7%
Ilio-Femoral  17  10.3%
Femoro-Femoral  25  14.4%
Femoro-Popliteal  62  35.6%
Femoro-Tibial  24  13.8%
Femoro-Peroneal  4  2.3%
Femoro-Dorsalis
pedis
7 4.0%
Thromboembolectomy  33  11.8%
Angioplasty/Endarterectomy  19  6.8%
EVAR  30  10.8%
TEVAR  2  0.7%
Arteriorraphy  12  4.3%
Ballon  Angioplasty  4  1.4%
Femoral  Artery
Exploration
3  1.1%
Bypass  Removal  3  1.1%
TOTAL  279  100%
EVAR, Endovascular Aneurysm Repair; TEVAR, Thoracic Endovas-
cular Aortic Repair.
i
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Table  3  Perioperative  characteristics.
N  (%)
Antiaggregation  at
admission
162/279 58.1%
Previous  ipsilateral
angiography  <  1
year
148/279  53.0%
History  of  ipsilateral
revascularization  <
1 year
56/279  20.1%
Ipsilateral  infection
at  admission
57/279 20.4%
Emergency  88/279 31.5%
Prophylactic 252/279  90.3%
9
d
o
w
o
d
l
I
i
died  from  sepsis.Previous  revascularization  with  open  surgery  involved  the
psilateral  inguinal  area  in  18.8%  of  the  infected  patients
3/16)  and  56.3%  had  a  history  of  previous  femoral  artery
uncture  (9/16). t
Table  4  Comparison  of  patient  demographics,  clinical  and  preop
group.
Population  Contro
Men  181/22
Age, median,  years  69  
Comorbidities BMI, median,  Kg/m2 24,6  
DM 90/225
Hypertension 154/22
CVD 37/225
CAD 49/225
Current smoking  78/225
Previous smoking  (>6  months)  71/225
Hemodyalisis 14/225
Kidney transplantation  8/225  
Procedures  
Perioperative
Characteristics
Antiaggregation  at  admission  
Previous ipsilateral  angiography  <  1  year  
History of  ipsilateral  revascularization  <  1
Ipsilateral  infection  at  admission  
Emergency  
Prophylactic  antibiotic  
* BMI, Body Mass Index; DM, Diabetes Mellitus; CVD, Cerebrovascular Dantibiotic
Identiﬁcation  of  the  infecting  agent  was  possible  only  in
/16  patients.  The  most  common  isolated  agent  was  Pseu-
omonas  aeruginosa  (3/16).
All  infections  were  described  in  Table  6.  Empiric  antibi-
tic  treatment  was  instituted  after  clinical  diagnosis  of
ound  infection.  All  Szilagyi  I  resolved  with  antibiotic
nly;  Three  patients  with  Szilagyi  II  infections  needed
rainage/debridement  on  operation  room  --  the  others  Szi-
agyi  II  resolved  with  antibiotic  and  wound  care.  All  Szilagyi
II  were  treated  with  bypass  removal,  and  in  two  patients,  an
n  situ  revascularization  was  performed.  These  two  patientsOther  wound  complications  were  registered  and  men-
ioned  in  Table  7.
erative  characteristics  between  Control  group  and  Infection
l  (n  =  225)  Infection  (n  =  16)  P
5  (80.4%)  11/16  (68.8%)  .261
74  .428
25,9  .792
 (40%)  6/16  (37.5%)  .844
5  (68.4%)  15/16  (93.8%)  .033
 (16.4%)  2/16  (12.5%)  .679
 (21.8%)  5/16  (31.3%)  .389
 (34.7%)  6/16  (37.5%)  .818
 (31.6%)  2/16  (12.5%)  .109
 (6.2%)  -  -
(3.6%)  -  -
Control  (n  =  263)  Infection  (n  =  16)  P
152/263  (58%)  10/16  (62,5%)  .724
140/263  (53.2%)  9/16  (56.3%)  .791
 year  53/263  (19.8%)  3/16  (18.8%)  .857
55/263  (20.9%)  2/16  (12.5%)  .418
81/263  (30.8%)  7/16  (43.8%)  .279
239/263  (90.8%)  13/16  (81.3%)  .258
isease; CAD, Coronary Artery Disease.
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Table  5  Incidence  of  infection  by  type  of  procedure.
Procedure  N.◦ Grade  I  Grade  II  Grade  III  TOTAL
Bypass  with  synthetic  prosthesis 114  1  0.9%  2  1.7%  2  1.7%  5  4.3%
Bypass with  vein  graft  59  1  1.7%  0  -  1  1.7%  2  3.4%
Tromboembolectomy  33  1  3.0%  2  6.1%  0  -  3  9.1%
Arteriorraphy  12  0  -  2  16.7%  0  -  2  16.7%
Angioplasty/Endarterectomy  19  0  -  0  -  0  -  0  -
EVAR 30  1  3.3%  3  10%  0  -  4  13.3%
TEVAR 2  0  -  0  -  0  -  0  -
Balloon Angioplasty  4  0  -  0  -  0  -  0  -
Femoral Artery  Exploration 3  0  -  0  -  0  -  0  -
Bypass Removal 3  0  -  0  -  0  -  0  -
TOTAL 279 4  1.4% 9  3.2% 3  1.1%  16  5.7%
* EVAR, Endovascular Aneurysm Repair; TEVAR, Thoracic Endovascular Aortic Repair.
Table  6  Detailed  description  of  all  infections.
Infection  Pathology  Surgery  Day  of
diagnosis
Microbiology  Treatment  Result
Grade  II  Ischemia  Thromboembolectomy  Emergency  D22  -  ?  ?
Grade II  (1)  Ischemia  Thromboembolectomy  Emergency  D12  Acinetobacter
baumanii
Antibiotherapy  Recovered
Grade I  PAOD  Bypass  D2  Pseudomonas
aeruginosa
Antibiotherapy  Recovered
Grade I  Endoleak  EVAR  D22  -  Antibiotherapy  Recovered
Grade I  Hemorrhage  Bypass  Emergency  D2  -  Antibiotherapy  Recovered
Grade II  DAOP  Bypass  D8  Enterococcus
faecium
OR:  Drainage  Recovered
Grade II  AAA  EVAR  Emergency  D25  -  Antibiotherapy  Recovered
Grade I  Ischemia  Thromboembolectomy  Emergency  D2  -  Antibiotherapy  Recovered
Grade II  False
aneurysm
Arteriorraphy  Emergency  D22  -  Antibiotherapy  Recovered
Grade II False
aneurysm
Arteriorraphy  Emergency  D23  Proteus  vulgaris
Escherichia  coli
Antibiotherapy  Recovered
Grade II  AAA  EVAR  D10  Klebsiella
pneumoniae
OR:  Debridement  Recovered
Grade III  PAOD  Bypass  D14  Pseudomonas
aeruginosa
OR:  Removal
bypass
followed  by
revascularization
Dead
Grade II  Endoleak
AAA
EVAR  D9  Klebsiella
pneumoniae
Antibiotherapy  Recovered
Grade III  PAOD  Bypass  D3  Pseudomonas
aeruginosa
OR:  Removal
bypass
followed  by
revascularization
Dead
Grade II  PAOD  Bypass  D11  Streptococcus
agalactiae
Staphylococcus
aureus
OR:  Drainage  Recovered
Grade III  PAOD  Bypass  D17  -  OR:  Removal
bypass
Recovered
* PAOD, Peripheral Arterial Occlusive Disease; AAA, Abdominal Aortic Aneurysm; EVAR, Endovascular Aneurysm Repair; OR, Operation
Room.
(1) Bilateral infection.
8  G.  Teixeira  et  al.
Table  7  Other  complications  per  procedure.
Incidence  Drainage  in  operation  room
Lymphorrage
Bypass  10/173  5.8%  2/10
Thromboembolectomy  1/33  3.0%  -
Angioplasty/Endarterectomy  2/19  10.5%  1/2
EVAR 1/30  3.3%  -
Arteriorraphy  3/12  25.0%  1/3
Femoral Artery  Exploration  1/3  33.3%  1/1
TOTAL 18/279  6.5%  5/18  (27.8%)
Hematoma
Bypass 4/173 2.3% 2/4
Angioplasty/Endarterectomy  2/19  16.7%  -
EVAR 3/30  10%  -
TOTAL 9/279  3.2%  2/9  (22.2%)
* EVAR, Endovascular Aneurysm Repair.
• 210 just one procedure
• 26 one reintervention
• 3 two reinterventions
• 2 three reinterventions
241 patients
• 210 single procedures
• 66 ipsilateral reinterventions
• 3 contralateral reinteventions
279 procedures
•13 infections
•17 lymphorrages
• 7 hematomas
210 one intervention
• 3 infections
• 1 lymphorrages
• 2 hematomas
66 ipsilateral reinterventions
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As  redo  operations  are  a  consistent  risk  factor  for  surgical
ite  infections,  we  compared  the  infection  rates  accord-
ng  to  the  number  of  reinterventions  (Figure  2).  Three  out
f  31  reoperated  patients  were  subjected  to  contralateral
rocedures,  so  they  were  not  truly  redo  operations  and
ere  excluded,  leaving  28  redo  patients  to  compare  with
10  patients  treated  with  just  one  procedure  during  2013.
ubgroup  analysis  showed  that  hemodialysis  was  a  risk  fac-
or  for  reintervention  (5/28  vs  8/210,  p  =  0.002).  As  for
omplications  after  reintervention,  we  had  3/66  infections,
/66  lymphorrage  and  2/66  hematomas.  No  statistically
igniﬁcant  difference  was  found  in  the  outcomes  between
e-operated  patients  and  one-time  operated  patients.
iscussionost  wound  complications  (hematoma,  seroma  and  dehis-
ence)  and  superﬁcial  infections  of  surgical  site  are  easily
reated,  but  frequently  neglected  by  the  vascular  surgeon.
d
s
t
crvention  and  multiple  reinterventions.
owever,  they  are  assumed  risk  factors  for  deeper  infections
xtending  to  the  graft,  which  are  associated  with  cata-
trophic  consequences:  death  rate  between  15  to  75%  and
ajor  amputations  rate  up  to  70%.11 Even  when  the  treat-
ent  is  successful,  the  morbidity  associated  with  vascular
raft  infection  is  considerable,  the  outcomes  often  being
orse  than  the  natural  history  of  the  vascular  condition
hat  led  to  graft  implantation.2 Vascular  surgeons  should
aintain  a  low  threshold  for  proceeding  with  additional
iagnostic  testing  when  any  symptom  or  sign  suggests  graft
nfection.
In a  case-controlled  study  reported  by  Antonios  et  al.,
ultivariate  analysis  identiﬁed  only  groin  incision  and
ound  infection  as  factors  increasing  the  risk  of  subsequent
ascular  graft  infection.12 Dennis  F  Bandyk  added  that,  for
he  vascular  patient,  obesity,  advanced  age,  smoking  and
iabetes  were  characteristics  that  potentiate  SSI.1 In  our
tudy  we  found  that  hypertension  rate  was  higher  in  patients
hat  got  infection  (p  =  0.03),  but  no  other  study  found  this
orrelation.
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ventive measures. Semin Vasc Surg. 2008;21(3):119--23.
2. Cronenwett JL, Johnston WK.  Rutherford’s Vascular Surgery.
Philadelphia: Elsevier. 2014:654--72.Groin  wound  infection  in  vascular  surgery  
We  had  an  incidence  of  SSI  at  the  groin  after  vascular
procedures  of  4.7%:  a  good  mark  comparing  with  an  over-
all  incidence  described  in  the  range  of  3  to  44%.3 However,
a  possible  explanation  for  the  differences  in  the  reported
incidence  could  be  the  deﬁnition  of  SSI  used.
Most  bacterial  infections  occur  from  direct  spread  of
bacteria  from  the  wound  surface.4 Therefore,  our  focus
must  be  in  the  prevention  of  surgical  site  infection.  In  our
center  antibiotic  prophylaxis  was  administered  to  90.3%  of
the  patients.  There  is  clear  evidence  that  this  is  effec-
tive  for  SSI  prevention  in  vascular  surgery.  Other  protocol
prophylactic  measures  used  (previous  bath  with  chlorhexi-
dine,  trichotomy  immediatly  before  surgery,  skin  antisepsis
with  alcoholic  solution,  intraoperative  glove  change,  closed
suction  drain  placement,  careful  hemostasis  and  layered  clo-
sure)  are  recommended  but  do  not  have  the  same  level  of
evidence.4
The  prophylactic  antibiotic  of  choice  in  our  department  is
cefazolin.13,14 Cefazolin  is  a  ﬁrst-generation,  low  cost,  low
toxicity  cephalosporin,  active  against  methicillin-sensitive
Staphylococcus  aureus,  coagulase  negative  Staphylococcus
and  some  Gram-negative  bacilli.  The  initial  dose  is  twice
the  usual  (usually  1-2  g  EV)  and,  in  longer  surgeries,  booster
doses  are  administered  every  4  hours.  Cefazolin  is  admin-
istered  60  minutes  before  surgery  and  administration  is
completed  before  incision.  In  patients  already  under  antimi-
crobial  treatment  an  extra  dose  60  minutes  before  the
surgical  incision  is  administered.
We  signalized  a  history  of  arterial  puncture  at  the  site
of  infection  in  56.3%  of  the  patients  that  develop  SSI.  The
signiﬁcant  association  described  elsewhere  between  preop-
erative  inguinal  arteriography  and  groin  infection  conﬁrms
the  necessity  of  adopting  speciﬁc  preventive  measures  to
avoid  the  high  morbidity  and  mortality  inherent  to  this  vas-
cular  surgery  complication.15
Recently,  negative  pressure  dressing  combined  with
standard  perioperative  infection  prevention  has  shown  to
signiﬁcantly  decrease  the  incidence  of  groin  SSIs  in  patients
undergoing  vascular  procedures  in  one  single  center.3
Although  virtually  any  microorganism  can  infect  a vas-
cular  prosthesis,  S.  aureus  is  the  most  prevalent  pathogen
and  accounts  for  one  fourth  to  one  half  of  the  infec-
tions  depending  on  the  implant  site.  Early  infections  are
caused  by  virulent  hospital-acquired  bacteria  and  frequently
associated  with  sepsis,  as  evidenced  by  fever,  leukocyto-
sis,  bacteremia  and  an  advanced  wound  infection.  Late
infections  result  from  graft  colonization  by  low-virulence
organisms  such  as  Staphylococcus  epidermiditis. The  low
titer  of  microorganisms  on  graft  surfaces  produces  an  indo-
lent  infection  without  signs  of  sepsis,  and  cultures  of
perigraft  ﬂuid  or  tissue  may  yield  no  growth.  Although  typ-
ically  less  virulent,  these  infections  are  more  established
and  difﬁcult  to  eradicate  locally.2 In  our  study,  the  highest
incidence  of  infection  with  more  aggressive  pathogens  was
coincident  with  the  characteristics  of  early  infections  and
may  support  that  prevention  measures  applied  were  effec-
tive  in  preventing  wound  infection  by  commensal  bacteria
of  the  skin  ﬂora.The  empirical  antibiotic  therapy  should  cover  methiclin-
resistant  S.  aureus  and  gram  negative  bacilli. Associa-
tions  with  beta  lactams,  daptomycin  or  vancomycin  and
aminoglycosides  seems  the  best  option.17 Among  the9
nti-staphylococcal  drugs  available,  the  preference  for  dap-
omycin,  rather  than  vancomycin,  has  been  growing  due  to
ts  bactericidal  activity,  ability  to  prevent  bacterial  adhe-
ion,  capacity  to  penetrate  into  bioﬁlm  and  to  prevent  the
ormation  of  bioﬁlm  itself.16 A  synergistic  effect  when  used
ith  rifampin  has  been  described.17
Multiple  surgical  treatment  modalities  have  been
ttempted  with  limited  success  and  increased  health  care
osts,  including  rotational  ﬂaps,  wound  vacuum-assisted
losure  and  excision  of  prostheses  with  extra-anatomic
ypass.  In  femorodistal  bypass,  in  the  absence  of  bleeding  or
evere  sepsis,  aggressive  local  treatment  with  debridement
nd  drainage  of  localized  collections,  bactericidal  broad-
pectrum  antibiotics  and  use  of  muscle  ﬂaps,  was  associated
ith  lower  rates  of  limb  amputation  and  with  reinfection
nd  mortality  rates  similar  to  conventional  therapy  which
nvolves  the  excision  of  the  graft,  with  or  without  arte-
ial  reconstruction.6,18,19 In  our  study,  the  two  patients  with
raft  infection  and  in  whom  revascularization  was  tried,  did
ot  survive.  These  two  fatal  results  are  a  red  ﬂag  for  the
evastating  consequences  that  may  arise  from  surgical  site
nfection,  and  may  be  a  stop  to  endless  revascularization
ttempts.
onclusions
n  addition  to  showing  our  low  incidence  rate  of  groin  SSI,
his  study  offers  the  opportunity  to  review  risk  factors,  pre-
entive  measures  and  therapeutic  modalities  in  vascular
nfections.  Our  rate  of  groin  infection  is  consistent  with  the
est  international  reports.  Strategies  for  infection  control
eﬁned  over  years  may  contribute  to  these  excellent  results.
he  difﬁculty  in  establishing  a  correlation  between  infec-
ion/risk  factors  and  infection/preventing  measures  results
rom  the  low  incidence  of  groin  infection  and  the  necessity
or  longer  follow-up  periods
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